CYBX: Analysis & Opinions

  1. Dismal 4Q for Quest Diagnostics - Analyst Blog

    January 23, 2013
    Leading diagnostic testing company, Quest Diagnostics (DGX) reported earnings per share ("EPS") from continuing ...
  2. PetMed Revs in Line, Margins Up - Analyst Blog

    January 23, 2013
    America's largest pet pharmacy, PetMed Express (PETS) reported earnings of 23 cents per share in the third quarter ...
  3. Intuitive Beats Zacks Estimates - Analyst Blog

    January 23, 2013
    Intuitive Surgical (ISRG) reported fourth quarter and 2012 earnings per share of $4.25 and $15.98, respectively, ...
  4. Cepheid Unveils Prelim 4Q Results - Analyst Blog

    January 10, 2013
    Recently, Cepheid (CPHD) reported selected results for fourth quarter of 2012 based on preliminary analysis. The ...
  5. FDA Nod for Cepheid's Latest Test - Analyst Blog

    December 28, 2012
    Cepheid (CPHD) recently disclosed that the U.S. Food and Drug Administration (FDA) has granted clearance to market ...
  6. Cyberonics Attains New Landmark - Analyst Blog

    December 24, 2012
    Neuromodulation company, Cyberonics (CYBX) announced the 100,000th patient implant of its Vagus Nerve Stimulation ...
  7. Cyberonics (CYBX) - Bull of the Day

    December 10, 2012
    Cyberonics Inc. (CYBX) reported a 37.5% year over year growth in adjusted EPS of 0.44 in the second quarter 2013, ...
  8. Cyberonics Reiterated at Outperform - Analyst Blog

    November 29, 2012
    We recently maintained our Outperform recommendation on Cyberonics (CYBX), a major neuromodulation company, with a ...
  9. Regeneron Pharmaceuticals and More Big Movers on the ...

    November 16, 2012
    The market has been slipping so far today: the Nasdaq is trading down 1%; the S&P 500 is down 0.6%; and the Dow has ...
  10. Regeneron Pharmaceuticals Among Healthcare's Biggest ...

    November 16, 2012
    The market is currently down, with the Nasdaq slipping 1%, the S&P 500 declining 0.6% and the Dow falling 0.8%. The ...
  11. Gilead and Other Big Movers on the Nasdaq on November ...

    November 12, 2012
    Currently, the Nasdaq has declined 0.1%, the S&P 500 is unchanged and the Dow has slipped 0.1%. The recent surge in ...
  12. Gilead Among Healthcare's Biggest Movers on November 12, ...

    November 12, 2012
    The Nasdaq has decreased 0.1%, the S&P 500 has moved little and the Dow is trading down 0.1% so far today. The ...
  13. Gilead Among Healthcare's Biggest Movers on October 2, 2012

    October 02, 2012
    So far today, the Nasdaq has climbed 0.4%, the S&P 500 is up 0.1% and the Dow is trading down 0.2%. The healthcare ...
  14. Cyberonic Ventures in Germany - Analyst Blog

    September 21, 2012
    Leading neuromodulation company, Cyberonics Inc. (CYBX) made an initial investment of €2 million in a German ...
  15. Cyberonics Upgraded to Outperform - Analyst Blog

    September 04, 2012
    We recently upgraded our recommendation on Cyberonics (CYBX), a major neuromodulation company, to Outperform ...
  16. Healthcare Stocks, Including Warner, Making Big Moves on ...

    August 29, 2012
    Currently, the Nasdaq has decreased 0.2%, the S&P 500 has been relatively flat and the Dow has remained steady. The ...
  17. Encouraging 1Q for Cyberonics - Analyst Blog

    August 29, 2012
    Cyberonics (CYBX), a neurological device maker, reported earnings per share ("EPS") of 29 cents in the first quarter ...
  18. ASML Holding N.V and Other Nasdaq Stocks Making Big ...

    August 28, 2012
    After a bad morning, the Nasdaq has slipped 0.1%, the S&P 500 has fallen 0.1% and the Dow is trading down 0.1%. The ...
  19. Pharmacyclics Among Healthcare's Biggest Movers on ...

    August 28, 2012
    On a bad day for the market, the Nasdaq has slipped 0.1%, the S&P 500 is trading down 0.1% and the Dow has decreased ...
  20. Earnings Preview: Cyberonics - Analyst Blog

    August 24, 2012
    Leading neuromodulation company, Cyberonics Inc. (CYBX) is scheduled to report its first quarter fiscal 2013 results ...
Marketplace
Trading Center